[{"id":"63f349ce-a04f-4a3b-be1c-95c92b63feca","acronym":"","url":"https://clinicaltrials.gov/study/NCT03194685","created_at":"2021-01-18T15:45:12.630Z","updated_at":"2024-07-02T16:36:13.122Z","phase":"Phase 1/2","brief_title":"Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia","source_id_and_acronym":"NCT03194685","lead_sponsor":"Fujifilm Pharmaceuticals U.S.A., Inc.","biomarkers":" FLT3","pipe":" | ","alterations":" FLT3 mutation","tags":["FLT3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FLT3 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FF-10101"],"overall_status":"Completed","enrollment":" Enrollment 97","initiation":"Initiation: 05/05/2017","start_date":" 05/05/2017","primary_txt":" Primary completion: 07/31/2021","primary_completion_date":" 07/31/2021","study_txt":" Completion: 07/31/2021","study_completion_date":" 07/31/2021","last_update_posted":"2022-04-12"}]